AI Tokens
Stock Analysis on Net

HCA Healthcare Inc. (NYSE:HCA)

This company has been moved to the archive! The financial data has not been updated since May 3, 2022.

Analysis of Investments

Microsoft Excel

Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities

HCA Healthcare Inc., adjustment to net income attributable to HCA Healthcare, Inc.

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net income attributable to HCA Healthcare, Inc. (as reported) 6,956 3,754 3,505 3,787 2,216
Add: Unrealized gains (losses) on available-for-sale securities (13) 11 11 (5) 1
Less: Realized gains included in other operating expenses — — — — (1)
Net income attributable to HCA Healthcare, Inc. (adjusted) 6,943 3,765 3,516 3,782 2,216

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


The financial results demonstrate a consistent upward trajectory in both reported and adjusted net income from 2017 through 2021. Total reported net income increased from 2,216 million US dollars in 2017 to 6,956 million US dollars in 2021, with the most significant growth surge occurring between 2020 and 2021.

Net Income Variance Analysis
The difference between reported and adjusted net income remains minimal throughout the observed period. In 2017, there was no variance between the two figures. From 2018 to 2021, the variance fluctuated between a maximum of 13 million US dollars and a minimum of negative 11 million US dollars, indicating that adjustments have a negligible impact on the overall profitability profile.
Mark-to-Market Adjustments
The adjustments related to mark-to-market available-for-sale securities are immaterial relative to total net income. Reported net income was higher than adjusted net income in 2018 and 2021, while it was lower in 2019 and 2020. These marginal shifts suggest that the valuation of available-for-sale securities did not introduce significant volatility into the net earnings.
Growth Correlation
A high degree of correlation exists between reported and adjusted net income trends. Both metrics followed an identical growth pattern, characterized by a steady increase from 2017 to 2018, a slight contraction in 2019, a recovery in 2020, and a substantial expansion in 2021.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Profitability Ratios: Mark to Market Available-for-sale Securities (Summary)

HCA Healthcare Inc., Profitability Ratios: Reported vs. Adjusted

HCA Healthcare Inc., adjusted profitability ratios

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net Profit Margin
Reported net profit margin 11.84% 7.28% 6.83% 8.11% 5.08%
Adjusted net profit margin 11.82% 7.31% 6.85% 8.10% 5.08%
Return on Equity (ROE)
Reported ROE — 656.29% — — —
Adjusted ROE — 658.22% — — —
Return on Assets (ROA)
Reported ROA 13.71% 7.90% 7.78% 9.66% 6.06%
Adjusted ROA 13.68% 7.93% 7.80% 9.65% 6.06%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


Profitability and return metrics exhibit an overall upward trajectory from 2017 through 2021, with a notable acceleration in performance during the final year. The correlation between reported and adjusted figures is extremely high, indicating that mark-to-market adjustments for available-for-sale securities have a negligible impact on the core profitability ratios.

Net Profit Margin Trends
The reported net profit margin increased from 5.08% in 2017 to a peak of 11.84% in 2021. A temporary contraction occurred in 2019, where the margin fell to 6.83% before recovering steadily through 2020 and 2021. The adjusted margins track these movements almost identically, with variances typically remaining within two basis points.
Return on Assets (ROA)
Return on assets followed a pattern consistent with net profit margins, rising from 6.06% in 2017 to 13.71% in 2021. After a peak of 9.66% in 2018, the ratio experienced a slight decline in 2019 but maintained stability in 2020 before the sharp increase in 2021. Adjusted ROA figures mirror this progression, showing no material deviation from reported values.
Return on Equity (ROE)
Data for return on equity is only available for the 2020 period, showing an exceptionally high reported value of 656.29% and an adjusted value of 658.22%. This significant percentage suggests a highly leveraged capital structure or a substantially reduced equity base relative to net income during that specific fiscal year.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Net Profit Margin

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
As Reported
Selected Financial Data (US$ in millions)
Net income attributable to HCA Healthcare, Inc. 6,956 3,754 3,505 3,787 2,216
Revenues 58,752 51,533 51,336 46,677 43,614
Profitability Ratio
Net profit margin1 11.84% 7.28% 6.83% 8.11% 5.08%
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in millions)
Adjusted net income attributable to HCA Healthcare, Inc. 6,943 3,765 3,516 3,782 2,216
Revenues 58,752 51,533 51,336 46,677 43,614
Profitability Ratio
Adjusted net profit margin2 11.82% 7.31% 6.85% 8.10% 5.08%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

2021 Calculations

1 Net profit margin = 100 × Net income attributable to HCA Healthcare, Inc. ÷ Revenues
= 100 × 6,956 ÷ 58,752 = 11.84%

2 Adjusted net profit margin = 100 × Adjusted net income attributable to HCA Healthcare, Inc. ÷ Revenues
= 100 × 6,943 ÷ 58,752 = 11.82%


The financial performance from 2017 to 2021 demonstrates a significant upward trajectory in overall profitability. Although a period of fluctuation occurred between 2018 and 2020, the company concluded the five-year sequence with a substantial increase in both absolute net income and profit efficiency.

Adjusted Net Income Trends
Adjusted net income rose from US$ 2,216 million in 2017 to US$ 6,943 million in 2021. A sharp increase was recorded in 2018, followed by a slight retraction to US$ 3,516 million in 2019. This was followed by a recovery in 2020 and a dramatic surge in 2021, where adjusted net income nearly doubled from the prior year's level.
Adjusted Net Profit Margin Analysis
The adjusted net profit margin expanded from 5.08% in 2017 to 11.82% in 2021. This growth was characterized by an initial jump to 8.10% in 2018, a temporary dip to 6.85% in 2019, and a subsequent climb that culminated in a period-high of 11.82%. The increase indicates a strengthened ability to manage operating costs relative to revenue generation over the observed timeframe.
Comparison of Reported and Adjusted Figures
A close correlation is observed between reported and adjusted profitability metrics. The variance between reported net profit margins and adjusted net profit margins remained marginal across all five years, suggesting that one-time charges or non-standard accounting adjustments did not materially distort the underlying financial performance.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
As Reported
Selected Financial Data (US$ in millions)
Net income attributable to HCA Healthcare, Inc. 6,956 3,754 3,505 3,787 2,216
Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc. (933) 572 (2,808) (4,950) (6,806)
Profitability Ratio
ROE1 — 656.29% — — —
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in millions)
Adjusted net income attributable to HCA Healthcare, Inc. 6,943 3,765 3,516 3,782 2,216
Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc. (933) 572 (2,808) (4,950) (6,806)
Profitability Ratio
Adjusted ROE2 — 658.22% — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

2021 Calculations

1 ROE = 100 × Net income attributable to HCA Healthcare, Inc. ÷ Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc.
= 100 × 6,956 ÷ -933 = —

2 Adjusted ROE = 100 × Adjusted net income attributable to HCA Healthcare, Inc. ÷ Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc.
= 100 × 6,943 ÷ -933 = —


Net income demonstrates a consistent upward trajectory over the five-year period from 2017 to 2021. Following a significant increase between 2017 and 2018, earnings remained relatively stable with a minor fluctuation in 2019, before experiencing a substantial surge in 2021.

Net Income Performance
Reported net income rose from 2,216 million USD in 2017 to 6,956 million USD by 2021. A notable acceleration in profitability is observed between 2020 and 2021, where reported net income increased by approximately 85%. Adjusted net income closely mirrors this trend, moving from 2,216 million USD in 2017 to 6,943 million USD in 2021, indicating that adjustments for non-recurring items had a negligible impact on the overall earnings profile.
Adjusted Return on Equity (ROE)
For the period ending December 31, 2020, the Adjusted ROE reached 658.22%, slightly exceeding the Reported ROE of 656.29%. This exceptionally high ROE value indicates a high degree of financial leverage or a significantly reduced equity base relative to the net income generated during that fiscal year.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
As Reported
Selected Financial Data (US$ in millions)
Net income attributable to HCA Healthcare, Inc. 6,956 3,754 3,505 3,787 2,216
Total assets 50,742 47,490 45,058 39,207 36,593
Profitability Ratio
ROA1 13.71% 7.90% 7.78% 9.66% 6.06%
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in millions)
Adjusted net income attributable to HCA Healthcare, Inc. 6,943 3,765 3,516 3,782 2,216
Total assets 50,742 47,490 45,058 39,207 36,593
Profitability Ratio
Adjusted ROA2 13.68% 7.93% 7.80% 9.65% 6.06%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

2021 Calculations

1 ROA = 100 × Net income attributable to HCA Healthcare, Inc. ÷ Total assets
= 100 × 6,956 ÷ 50,742 = 13.71%

2 Adjusted ROA = 100 × Adjusted net income attributable to HCA Healthcare, Inc. ÷ Total assets
= 100 × 6,943 ÷ 50,742 = 13.68%


The financial performance from 2017 to 2021 is characterized by an overall upward trajectory in both profitability and asset utilization efficiency. A significant acceleration in growth is observed in the final year of the period, where net income and return on assets reached their peak values.

Adjusted Net Income Trends
Adjusted net income grew from US$ 2,216 million in 2017 to US$ 6,943 million by 2021. A period of relative stability occurred between 2019 and 2020, with values fluctuating between US$ 3,516 million and US$ 3,765 million. The 2021 results represent a substantial increase of approximately 84% compared to the prior year.
Adjusted Return on Assets (ROA) Analysis
The Adjusted ROA mirrors the trajectory of net income, beginning at 6.06% in 2017 and increasing to 9.65% in 2018. Following a moderate decline to 7.80% in 2019 and a slight recovery to 7.93% in 2020, the ratio surged to 13.68% in 2021. This indicates a marked improvement in the efficiency of asset deployment and earnings generation toward the end of the analyzed timeframe.
Convergence of Reported and Adjusted Metrics
A high degree of convergence is observed between reported and adjusted figures across all years. The variance between reported and adjusted ROA remains minimal, such as in 2021 where the difference is only 0.03 percentage points. This suggests that non-recurring items or accounting adjustments had a negligible impact on the overall productivity of the asset base.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?